Komori
Medikit (7749) · PolicyRestated

Management indicators emphasizing sales, cost of sales ratios and profit margins

First written in FY2017. 3 of 5 entries say "Restated". Latest entry: FY2025.

5entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2021ReframedFY20222017: 120172018: 120182019: 020192020: 020202021: 120212022: 120222023: 020232024: 020242025: 12025
Same theme, other companies
Company-by-company profitability management based on revenue, cost ratios and operating marginsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Our group emphasizes consolidated net sales, the consolidated cost-of-sales ratio, consolidated gross profit and gross profit margin, and consolidated operating profit and operating profit margin.」

    The Company continues to use management indicators that emphasize the sales company’s net sales, the manufacturing company’s cost of sales and cost-of-sales ratio, and the consolidated operating profit margin.
  2. FY2022ReframedAnnual report

    「Our group emphasizes consolidated net sales, the consolidated cost-of-sales ratio, consolidated gross profit and gross profit margin, and consolidated operating profit and operating profit margin. In particular, the Company, which is a sales company, emphasizes net sales from the perspective of growth, while Togo Medikit Co., Ltd., a consolidated subsidiary and manufacturing company, emphasizes cost of sales and the cost-of-sales ratio from the perspective of profitability.」

    The wording changed from emphasizing consolidated ordinary profit and ordinary profit margin to emphasizing consolidated operating profit and operating profit margin. The focus on the sales company’s net sales and the manufacturing company’s cost of sales and cost-of-sales ratio continues.
  3. FY2021RestatedAnnual report

    「Our group emphasizes consolidated net sales, the consolidated cost-of-sales ratio, consolidated gross profit and gross profit margin, and consolidated ordinary profit and ordinary profit margin. In particular, the Company, which is a sales company, emphasizes net sales from the perspective of growth, while Togo Medikit Co., Ltd., a consolidated subsidiary and manufacturing company, emphasizes cost of sales and the cost-of-sales ratio from the perspective of profitability.」

    The disclosure reaffirms management indicators emphasizing the sales company’s net sales, the manufacturing company’s cost of sales and cost-of-sales ratio, and the consolidated profit margin.
  4. FY2018RestatedAnnual report

    「Our group emphasizes consolidated net sales, the consolidated cost-of-sales ratio, consolidated gross profit and gross profit margin, and consolidated ordinary profit and ordinary profit margin. In particular, the Company, which is a sales company, emphasizes net sales from the perspective of growth, while Togo Medikit Co., Ltd., a consolidated subsidiary and manufacturing company, emphasizes cost of sales and the cost-of-sales ratio from the perspective of profitability.」

    The disclosure reiterates the management indicators under which the sales company emphasizes net sales and the manufacturing company emphasizes cost of sales and the cost-of-sales ratio.
  5. FY2017First statedAnnual report

    「Our group emphasizes consolidated net sales, the consolidated cost-of-sales ratio, consolidated gross profit and gross profit margin, and consolidated ordinary profit and ordinary profit margin. In particular, the Company, which is a sales company, emphasizes net sales from the perspective of growth, while Togo Medikit Co., Ltd., a consolidated subsidiary and manufacturing company, emphasizes cost of sales and the cost-of-sales ratio from the perspective of profitability.」

    The disclosure presents company-specific management indicators, with the sales company emphasizing net sales and the manufacturing company emphasizing cost of sales and the cost-of-sales ratio.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medikit's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.